Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
International Journal of Biological Macromolecules|February 5, 2026
Reactive oxygen species-responsive Pluronic F127 hyaluronic hydrogel for targeted doxorubicin delivery in glioblastoma and enhanced survival with radiotherapyTsung-Yun Wu, Yen Pha Bui, Chin-Hua Chen, et al.Autophagy|September 2, 2021
LC3A-mediated autophagy regulates lung cancer cell plasticityChia-Cheng Miao, Wen Hwang, Ling-Yi Chu, et al.Nature Medicine|September 8, 2015
The association between sterilizing activity and drug distribution into tuberculosis lesionsBrendan Prideaux, Laura E Via, Matthew D Zimmerman, et al.Nature Medicine|April 5, 2016
Inflammatory signaling in human tuberculosis granulomas is spatially organizedMohlopheni J Marakalala, Ravikiran M Raju, Kirti Sharma, et al.The Journal of Clinical Investigation|February 11, 2020
Chronic mTOR activation induces a degradative smooth muscle cell phenotypeGuangxin Li, Mo Wang, Alexander W Caulk, et al.Cell Stem Cell|April 4, 2020
Smooth Muscle Cell Reprogramming in Aortic AneurysmsPei-Yu Chen, Lingfeng Qin, Guangxin Li, et al.Journal of Medicinal Chemistry|April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2αGuillaume Mata, Artur K Mailyan, Samuel L Drew, et al.Nature Metabolism|October 2, 2019
Endothelial TGF-β signalling drives vascular inflammation and atherosclerosisPei-Yu Chen, Lingfeng Qin, Guangxin Li, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.Journal of Medicinal Chemistry|September 1, 2020
Discovery of Potent and Selective PI3Kγ InhibitorsSamuel L Drew, Rhiannon Thomas-Tran, Joel W Beatty, et al.Pageof 16